Adverse events associated with immune checkpoint inhibitor treatment for cancer
2019
Key points
Inhibitors against cytotoxic T-lymphocyte–associated protein 4 and programmed cell death 1 immune checkpoints are novel agents that modulate immune pathways and enhance anti-tumour immunity. Their use has set new standards in the treatment of many cancer types. Some patients with
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
38
References
13
Citations
NaN
KQI